# Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension

> **NCT06683040** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **National Medical Research Center for Cardiology, Ministry of Health of Russian Federation** · enrollment: 260 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Oxacom
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06683040
- **Lead sponsor:** National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06683040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06683040, "Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06683040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*